【摘要】 目的探讨胸腔内注入尿激酶治疗结核性包裹性胸腔积液的疗效。方法结核性包裹性胸腔积液病人80例,随机分为注药组及对照组,每组各40例,注药组于胸腔内注入尿激酶10万U。比较两组胸腔积液引流量及胸腔膜厚度,测定注药治疗前后纤维蛋白降产物(FDP)含量。结果注药组胸腔积液引流量平均为(1921±208)mL,显著多于对照组的(1256±224)mL,(P<0.01);注药后胸膜厚度为(2.51±0.27)mm,显著低于对照组(3.46±0.31)mm,(P<0.05);注药前后FDP量分别为(2.3±1.7)mg/L,(18.2±5.6)mg/L,差异有显著性(P<0.01)。结论胸腔内注入尿激酶治疗结核性包裹性积液,疗效显著。更多还原

【Abstract】 [Objective] To investigate the effect by injecting abbokinase to cure the tuberculose encapsulated thoracic cavity hydrops. [Methods] The patients suffering from the tuberculose encapsulated thorcacic cavity hydrops 80 cases are divided into two groups-one group of injecting medicine and the other of contraposition. Each group is 40 cases. Inject the abbokinase 0.1 million U into the thoracic cavity, compare the drainage quantity and the thickness of the thoracic cavity. Measure the content of FDP of the injecting medicine group before and after cure. [Results] The average drainage quantity of the injecting group is (1921±208) mL, which is statistically higher than the contraposition group (1256±224) mL, (P <0.01); the thickness of the thoracic cavity after injecting medicine is (2.51±0.27) mm, which is statistically lower than the contraposition group (3.46±0.31) mm (P <0.05); and injecting medicine, the FDP is respectively (2.3±1.7) mg/L, (18.2±5.6) mg/L which has statistically difference (P <0.01). [Conclusion] The effect by injecting abbokinase to cure the tuberculose encapsulated thoracic cavity hydrops is very clear.更多还原